Insulin and forearm vasodilation in hypertension-prone men

Hypertension

Volumn 25, Issue 2, 1995, Pages 214-218

  Hulthén, U Lennart ^a,b   Endre, Tomas ^a   Mattiasson, Ingrid ^a   Berglund, Göran ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

forearm; glucose clamp technique; hypertension, family history of; insulin; insulin resistance

Indexed keywords

ADRENALIN; GLUCOSE; INSULIN; NORADRENALIN;

ADULT; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FOREARM BLOOD FLOW; GENETIC PREDISPOSITION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; MUSCLE BLOOD FLOW; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION;

EID: 0028831051     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.25.2.214     Document Type: Article

References (36)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei M, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
2. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
3. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med. 1992;91:589-596.
4. Facchini F, Chen IYD, Clinkingbeard C, Jeppesen J, Reaven GM. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens. 1992;5:694-699.
5. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive patients. BMJ. 1993;307:92-96.
6. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T. Impaired insulin sensitivity in young lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens. 1993;11:421-426.
7. Endre T, Mattiasson I, Hulthén UL, Lindgärde F, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens. 1994;12:81-88.
8. Capaldo B, Lembo G, Nappoli R, Rendina V, Albano G, Saccà L, Trimarco B. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism. 1991;40:1320-1322.
9. Laakso M, Edelman SV, Olefsky JM, Brechtel G, Wallace P, Baron AD. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 1990;39:965-974.
10. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844-1852.
11. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076-1083.
12. Julius S, Guldbrandsson T, Jamerson K, Shahab ST, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens. 1991;9:983-986.
13. Ferrannini E. Insulin and blood pressure: possible role of hemodynamics. Clin Exp Hypertens A. 1992;14:271-284.
14. World Health Organization Expert Committee on Diabetes Mellitus. Third report. WHO Technical Report Series 727. 1985:9-13.
15. Hulthén UL, Bolli P, Amann FW, Kiowski W, Bühler FR. Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. Hypertension. 1982;4(suppl II):II-26-II-31.
16. De Fronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method of quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
17. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977;21:625-636.
18. Heding LG. A simplified insulin radioimmunoassay method. In: Donato L, Milhaud G, Sirchis I, eds. Labelled Proteins in Tracer Studies. Brussels, Belgium: Euratom; 1966:345-350.
19. Rooney DP, Neely RDG, Ennis CN, Bell NP, Sheridan B, Atkinson AB, Trimble ER, Bell PM. Insulin action and hepatic glucose cycling in essential hypertension. Metabolism. 1992;41:317-324.
20. Peiris AN, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: influence of body fat distribution. J Clin Invest. 1986;78:1648-1657.
21. Mondon CE, Reaven GM. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism. 1988;37:303-305.
22. Mondon CE, Reaven GM, Azhar S, Lee CM, Rabkin R. Abnormal insulin metabolism by specific organs from rats with spontaneous hypertension. Am J Physiol. 1989;257:E491-E498.
23. Duckworth WD, Gifford D, Kitabachi AE, Runyan K, Solomon SS. Insulin binding and degradation by muscles from streptozotocin-diabetic rats. Diabetes. 1979;28:746-748.
24. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanism of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980;65:1272-1284.
25. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219-225.
26. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
27. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode recordings in healthy subjects. Diabetologia. 1992;35:873-879.
28. Anderson E, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension. 1993;21:136-141.
29. Clutter WE, Bier DM, Shah BS, Cryer PE. Epinephrine plasma metabolic clearance rates and physiological thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 1980;66:94-101.
30. Hjemdahl P, Fagius J, Freyschuss U, Wallin BG, Daleskog M, Bohlin G, Perski A. Muscle sympathetic activity and norepinephrine release during mental challenge in humans. Am J Physiol. 1989;257:E654-E664.
31. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;19:621-627.
32. Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Arcangeli M, Aoki T, Sorensen J, Berger M, Sonksen P, Gerich J. Skeletal muscle glycolysis, oxidation and storage of an oral glucose load. J Clin Invest. 1986;81:1563-1571.
33. Natali A, Buzzigoli G, Taddei S, Santoro D, Cerri M, Pedrinelli R, Ferrannini E. Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes. 1990;39:490-500.
34. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.
35. Doria A, Fioretto P, Avogar A, Carraro A, Morocutti A, Trevisan R, Frigato F, Crepaldi G, Viberti G, Nosadini R. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol. 1991;261:E684-E691.
36. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increasing blood pressure and body mass. Lancet. 1993;342:707-709.